|
|
Home > Healthcare > Biotechnology > General Biotech
ViroPharma Incorporated - SWOT Analysis
|
| Published Date:
August 2008
Published By:
Datamonitor
Page Count:
24
Order Code:
R313-34935
|
|
|
|
Datamonitor's ViroPharma Incorporate. SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
ViroPharma is a biopharmaceutical company focused on the development and commercialization of products that address serious infectious diseases. The company currently markets Vancocin HCl capsules, the oral capsule formulation of vancomycin hydrochloride, in the US. ViroPharma is headquartered in Exton, Pennsylvania and employed 130 people as of June 2008. The company recorded revenues of $203.8 million during the fiscal year (FY) ended December 2007, an increase of 21.9% over 2006. The revenue growth is mainly due to the $37.2 million increase in product sales. The operating profit of the company was $115.8 million during FY2007, an increase of 17.2% over 2006. The net profit was $95.4 million in FY2007, an increase of 43% over 2006.
Scope of the Report- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
|
Similar Products
• Biophotonics: A Strategic Assessment of Photonics Technologies for Biomedical Applications, 2nd Edition
Published Dec 2008 by Kalorama Information
• Biotechnology Report
Published Nov 2008 by Wall Street Transcript
• MarketWatch: Biotechnology
Published Nov 2008 by Datamonitor
• Amgen Inc. - SWOT Analysis - SWOT Analysis
Published Nov 2008 by Datamonitor
• The Royalty Rate Report 2009: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
Published Nov 2008 by PharmaVentures Ltd.
• 13th Annual International Detection Technologies 2008 Conference Documentation
Published Nov 2008 by Knowledge Foundation
• Freedonia Focus on Biochip Products & Services
Published Nov 2008 by Freedonia Focus
• Effective Competitive Intelligence: A "How-To" Guide for Life Science Companies
Published Nov 2008 by Kalorama Information
• Biodetection Technologies 5th Edition
Published Nov 2008 by Knowledge Foundation
• Biotechnology in the US - Industry Risk Rating Report
Published Oct 2008 by IBISWorld
|
|
|
|
0 items
